• PA
    PA School SurvivalDidactic Year
Study
  • Dashboard
  • Medical Terminology
  • Flashcards
  • Progress
  • Prep Rounds
  • Body Systems
  • Pharmacology
  • Tools
  • Guide & FAQ
  • Suggest a FeatureLet us know what we can do better — we genuinely want to help you in class.
My material
  • My Library
  • Notes & Sketches
PANCE Body Systems
  • Cardiovascular
    11%
  • Pulmonary
    9%
  • Gastrointestinal/Nutrition
    8%
  • Musculoskeletal
    8%
  • Neurology
    7%
  • Infectious Disease
    7%
  • Psychiatry/Behavioral
    7%
  • Reproductive
    7%
  • Endocrine
    6%
  • Eyes/Ears/Nose/Throat
    6%
  • Hematology
    5%
  • Renal
    5%
  • Genitourinary
    4%
  • Dermatology
    4%
Weights are study aids — verify each exam cycle.
⌘K
NotesPricingSign in
About·Tools·Terminology·Privacy Policy·Terms of Service·PANCE Blueprint

PANCE® is a registered trademark of the National Commission on Certification of Physician Assistants (NCCPA). This application is an independent study resource and is not affiliated with, sponsored by, or endorsed by the NCCPA.

For educational use only. Content is AI-generated, may contain errors, and is not medical advice — always verify against current primary sources and faculty guidance before clinical use.

Flashcards

Active recall over every profile. Pick a scope, reveal, and self-grade — “Again” sends a card back to the end of the deck.

Card 1 of 6
DiseasePsychiatry/Behavioral

Major Depressive Disorder

Recall: Pathophysiology · S/Sx · Gold Standard Dx · First-line Tx · Pearl

Tap or press Space to reveal
DiseasePsychiatry/Behavioral

Major Depressive Disorder

Pathophysiology
Multifactorial — monoamine (serotonin/norepinephrine/dopamine) dysregulation, HPA-axis overactivity, genetics.
S/Sx
≥2 weeks of depressed mood/anhedonia plus SIGECAPS (sleep, interest, guilt, energy, concentration, appetite, psychomotor, suicidality).
Gold Standard Dx
Clinical (DSM-5): ≥5 of 9 symptoms for ≥2 weeks, including mood or anhedonia (PHQ-9 to screen).
First-line Tx
SSRIs first-line + psychotherapy (CBT); allow 4–6 weeks for response.

Screen with SIGECAPS; SSRIs are first-line — assess suicidality and allow weeks for effect.